EUVIMED · CrossrefJournal
The Lancet Medical Imaging & Theranostics
ISSN 3117-4523 · Elsevier BV
Latest articles
Skull bone marrow TSPO PET signal in migraine: a cross-sectional association study
Determinants and prognostic significance of myocardial blood flow on cardiovascular magnetic resonance in dilated cardiomyopathy: a multicentre cohort study
Comparison of a deep learning-based radiomics score with Kellgren–Lawrence grading for prediction of knee replacement risk: a multicentre cohort study
CT-derived total lung volume and mortality risk in smokers with preserved ratio impaired spirometry: a lung cancer screening cohort study
Is intra-arterial application of targeted radionuclide therapy in neuro-oncology worth the effort? A framework for evidence generation
A continuous score for knee replacement risk from radiographs: promise, limitations, and the path beyond
Imaging-based classification of blood–brain barrier disruption in glioblastoma for patient selection in clinical trials: the NMN-BBB score
Prostate-specific membrane antigen PET–CT for diagnosis in patients with suspected prostate cancer: a post-hoc analysis of the randomised, controlled, phase 3 RAPID trial
Low-dose CT for MRI-free quantification of tau PET in Alzheimer’s disease: a multicentre, cross-sectional, comparison study
Dosimetry as the compass of radiotheranostics: from fixed activity to true precision
Towards reduced climate impact of ultrasound contrast agents
Prognostic value of 1-year [18F]FDG-PET–CT-defined complete metabolic response in metastatic clear-cell renal cell carcinoma: a multicentre, observational cohort study in China
Neuroimaging growth curves in children and young adults aged 6–20 years in the Netherlands: a population-based cohort substudy of the Generation R Study
Another piece of the evidence puzzle: is prostate-specific membrane antigen PET–CT a valuable tool for risk stratification?
Integrating radiotheranostics into national cancer planning to avoid widening cancer survival gaps: the case for equity-adjusted value
PSMA-targeted radioligand therapy with [177Lu]Lu-PSMA-I&T in metastatic castration-resistant prostate cancer: a prospective, multicentre, Swiss registry study
Limitations of the NMN-BBB score in capturing therapeutic accessibility
Predicting brain tumour enhancement from non-contrast MRI with artificial intelligence: a multicohort, retrospective, diagnostic accuracy study
Investigation of TDP-43 and annexin A11 contributions to off-target tau-PET binding in frontotemporal lobar degeneration: a retrospective, observational study
Residual lesions, resolved disease: redefining response in metastatic renal cell carcinoma
Hierarchical phase-contrast tomography: synchrotron x-ray imaging bridges the gap between histology and radiology
Geometric brain signatures for characterising hereditary ataxia and predicting functional brain organisation: a retrospective multicohort study
[177Lu]Lu-SSO110 with [68Ga]Ga-SSO120 companion imaging in patients with extensive-stage small-cell lung cancer (LuSato-1): a multicentre, phase 1, dose-escalation study
Limitations of the NMN-BBB score in capturing therapeutic accessibility
Association between multimorbidity, disease accumulation, multimorbidity clusters, and medical-imaging use and costs: a longitudinal study
Rethinking prostate cancer screening: finding what matters
Diffusion bridge networks simulate clinical-grade PET from MRI for dementia diagnostics: a retrospective cohort study
Seeing further, together
Is gadolinium use still justified in MRI? Predicting enhancement to guide contrast use in neuro-oncology
What does tau PET really see? Beyond tau in the era of precision neuroimaging
EUVIMED